Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOBR Safe (SOBR) Cash & Equivalents: 2019-2025

Historic Cash & Equivalents for Safe (SOBR) over the last 7 years, with Sep 2025 value amounting to $4.7 million.

  • Safe's Cash & Equivalents rose 1447.16% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year increase of 1447.16%. This contributed to the annual value of $8.4 million for FY2024, which is 200.49% up from last year.
  • As of Q3 2025, Safe's Cash & Equivalents stood at $4.7 million, which was down 44.35% from $8.5 million recorded in Q2 2025.
  • In the past 5 years, Safe's Cash & Equivalents ranged from a high of $10.1 million in Q1 2025 and a low of $107,448 during Q1 2022.
  • Its 3-year average for Cash & Equivalents is $5.1 million, with a median of $4.7 million in 2025.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 7,615.36% in 2023, then tumbled by 92.62% in 2024.
  • Quarterly analysis of 5 years shows Safe's Cash & Equivalents stood at $882,268 in 2021, then spiked by 872.38% to $8.6 million in 2022, then tumbled by 67.48% to $2.8 million in 2023, then skyrocketed by 200.49% to $8.4 million in 2024, then skyrocketed by 1,447.16% to $4.7 million in 2025.
  • Its Cash & Equivalents stands at $4.7 million for Q3 2025, versus $8.5 million for Q2 2025 and $10.1 million for Q1 2025.